ClinicalTrials.gov
public full text
Public Domain
Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Bronchiectasis
The investigators hypothesise that nebulised hypertonic saline (6%) will increase the volume of sputum expectorated over a 24 hour period compared to nebulised isotonic saline (0.9%) in patients with mild to severe stable bronchiectasis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis Bronchiectasis#1086597
- Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis#917652
- The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis#1095695
- Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis#869747
- Efficacy of Nebulized Hypertonic Saline in the Treatment of Acute Bronchiolitis#833580
Record · ID 831844
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive